Icahn School of Medicine Mount Sinai — New York, New York

Icahn School of Medicine Mount Sinai is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine Mount Sinai has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Hepatocellular Carcinoma, Breast Cancer, Malignant Pleural Mesothelioma.

Sponsors: Eisai Co., Ltd., Stemline Therapeutics, Inc., Oncovir, Inc..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine Mount Sinai?

Icahn School of Medicine Mount Sinai has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine Mount Sinai conducted?

Icahn School of Medicine Mount Sinai has 6 clinical trials on record, with 2 currently active. Their work covers Hepatocellular Carcinoma, Breast Cancer, Malignant Pleural Mesothelioma.

Is Icahn School of Medicine Mount Sinai accredited by Crixeo Health?

Yes — Icahn School of Medicine Mount Sinai holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Icahn School of Medicine Mount Sinai?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.